semaglutide fda shortage status january 2025 declares end to Wegovy and Ozempic GLP-1 No Longer on FDA's – GLP-1 Pipeline Update: November 2025

Kalra S, Sahay R

Take the following dose on the regularly scheduled weekly day

Follow-up visits allow a clinician to assess side effects, appetite changes, hydration, blood pressure, blood sugar, bowel habits, sleep, and progress toward meaningful goals

For others, it may take a few weeks for the results to become evident

Both medications activate glucagon-like peptide-1 (GLP-1) pathways in the brain and pancreas, but tirzepatide adds a second mechanism by also targeting the glucose-dependent insulinotropic peptide (GIP) receptor

The effects are highly dependent on an individual's skin tone who takes these injections